U.S. Regulators Give Full Approval to Pfizer COVID-19 Vaccine

The video discusses the first vaccine to receive full approval in the US, moving beyond emergency use status. This approval comes amid the spread of the Delta variant, with the vaccine showing 91% effectiveness in preventing infection. The full license applies to those 16 and older, while emergency use continues for ages 12 to 15. A poll indicates that full approval may increase vaccination rates among the unvaccinated.

What is the effectiveness percentage of the vaccine in preventing infection according to clinical trial data?

• 95%

• 75%

• 91%

• 85%

For which age group does the full license of the vaccine apply?

• 12 and older

• 16 and older

• 18 and older

• 21 and older

Under what condition is the vaccine still available for those aged 12 to 15?

• Full approval

• Emergency use authorization

• Conditional approval

• Provisional license

According to the Kaiser Family Foundation poll, what fraction of unvaccinated people would be more likely to get vaccinated if the vaccine is fully approved?

• Three in ten

• Two in ten

• One in five

• Half

What is the main reason for the increased likelihood of vaccination among some unvaccinated individuals?

• Full approval of the vaccine

• Peer pressure

• Government mandate

• Increased availability